61 results
Page 2 of 4
8-K
EX-99.2
5fzb3e0h
15 Mar 21
PhaseBio Reports Fourth-Quarter and Full-Year 2020 Financial Results and Recent Business Highlights
8:10am
8-K
EX-99.1
1hgtm
12 Nov 20
PhaseBio Reports Recent Business Highlights and Third-Quarter 2020 Financial Results
4:12pm
8-K
EX-99.1
jdrqr
23 Oct 20
PhaseBio Provides Pemziviptadil (PB1046) Program Update
8:20am
S-3
EX-1.2
omo2s5
27 Dec 19
Shelf registration
5:28pm
S-3
83q ffq8xmq
27 Dec 19
Shelf registration
5:28pm
S-3
EX-4.2
vro9gaxpavbmybgnz60
27 Dec 19
Shelf registration
5:28pm
8-K
EX-99.3
capwkerzm533zha nah
14 Aug 19
Regulation FD Disclosure
12:00am
424B4
wyahq4gw9tekif41
12 Apr 19
Prospectus supplement with pricing info
4:32pm
DEF 14A
55212a4bztu3d2n1v
5 Apr 19
Definitive proxy
4:05pm
DRS
38ze97jwoqd8f147aykr
29 Mar 19
Draft registration statement
12:00am